Search results

3 items
  1. A call to reprioritise metrics to evaluate illicit drug policy

    02 April 2016
    In the media

    The Lancet - On April 19–21, 2016, the UN General Assembly Special Session on Drugs (UNGASS) will convene to chart a course for the future to tackle the world's drugs problem. The 2016 UNGASS represents a rare opportunity to reassess the global approach to drugs and to move towards drug policies that more effectively address the three UN pillars of peace and security, human development, and human rights. We believe that we need a new consensus that includes a commitment to revise the range of indicators used to assess and improve drug policy effectiveness.

  2. Will UNGASS 2016 be the beginning of the end for the ‘war on drugs’?

    Ann Fordham, Martin Jelsma
    17 March 2016
    Opinion

    Held this April, will the United Nations General Assembly Special Session be the turning point for the international drug control system?

  3. The ketamine controversy, continued

    Martin Jelsma
    06 March 2015
    Opinion

    The Commission on Narcotic Drugs (CND) in Vienna will decide next week between two opposite proposals by China and the WHO about international control of ketamine, an essential anaesthetic in human and veterinary medicine. China originally proposed bringing ketamine under the 1971 Convention’s most severe control regime of Schedule I, which would dramatically affect its availability for surgery in poor rural settings and emergency situations. The WHO Expert Committee reviewed all the evidence and advised against any international control of ketamine, arguing it would trigger a public health disaster.